OnCo
companiesCompany

PharmaMar

Spanish company that turns marine natural products into cancer drugs, including lurbinectedin and trabectedin.

Discovered lurbinectedin (Zepzelca, partnered with Jazz in the US) and trabectedin (Yondelis). IMforte success in 2025 broadened lurbinectedin into first-line maintenance.

Headquarters
Madrid, ES
Type
biotech · PHM.MC

Products

1top
ApprovedCytotoxic (transcription inhibitor)
Lurbinectedin · Zepzelca

A marine-derived chemotherapy that jams cancer's gene-reading machinery, approved for relapsed small-cell lung cancer and, since 2025, as first-line maintenance with atezolizumab.

Connected

5top

cancers

3
Ewing sarcomaSarcomas (soft tissue, bone, GIST)Small-cell lung cancer

fronts

1
Chemotherapy

drugs

1
ApprovedCytotoxic (transcription inhibitor)
Lurbinectedin · Zepzelca